World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
16491
World Ranking
1940
National Ranking
947

Stephen S. Whitehead publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen S. Whitehead sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 185 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen S. Whitehead D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen S. Whitehead sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stephen S. Whitehead is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily focuses on medicine, with significant contributions to public health, environmental and occupational health, infectious diseases, epidemiology, virology, and modeling and simulation.

Their work covers key topics including:

  • Mosquito-borne diseases and control
  • Viral infections and vectors
  • Malaria research and control
  • Virology and viral diseases
  • Viral infections and outbreaks research
  • COVID-19 epidemiological studies
  • Dengue and mosquito control research

Whitehead's recent papers include:

  • "Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults," 2024, New England Journal of Medicine
  • "Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial," 2020, The Lancet Infectious Diseases
  • "Antigenic evolution of dengue viruses over 20 years," 2021, Science
  • "T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species," 2020, Journal of Virology
  • "Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees," 2020, Cell Reports

Their frequent coauthors are:

  • Anna P. Durbin
  • Sean A. Diehl
  • Kristen K. Pierce
  • Beth D. Kirkpatrick
  • Usha K. Nivarthi

Whitehead has published multiple articles in venues such as:

  • UNC Libraries
  • The Lancet Infectious Diseases
  • Journal of Virology
  • The Journal of Infectious Diseases
  • New England Journal of Medicine

Best Publications

  • Prospects for a dengue virus vaccine.

    Stephen S. Whitehead;Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy

  • The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

    Martina Beltramello;Katherine L. Williams;Cameron P. Simmons;Annalisa Macagno

  • Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

    Ruth A. Karron;Deborah A. Buonagurio;Alice F. Georgiu;Stephen S. Whitehead

  • Immune Response to Dengue Virus and Prospects for a Vaccine

    Brian R Murphy;Stephen S Whitehead

  • Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

    Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn

  • Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.

    Alexander Bukreyev;Stephen S. Whitehead;Brian R. Murphy;Peter L. Collins

  • Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  • Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

    Michael N. Teng;Stephen S. Whitehead;Peter L. Collins

  • Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees

    Stephen S. Whitehead;Alexander Bukreyev;Michael N. Teng;Cai Yen Firestone

  • Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.

    Michael N. Teng;Stephen S. Whitehead;Alison Bermingham;Marisa St. Claire

  • The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

    Beth D. Kirkpatrick;Stephen S. Whitehead;Kristen K. Pierce;Cecilia M. Tibery

  • Dengue viruses cluster antigenically but not as discrete serotypes

    Leah C. Katzelnick;Judith M. Fonville;Judith M. Fonville;Judith M. Fonville;Gregory D. Gromowski;Jose Bustos Arriaga

  • Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.

    Cameron P. Simmons;Tran Nguyen Bich Chau;Tran Thi Thuy;Nguyen Minh Tuan

  • Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

    Joseph E. Blaney;Jennifer M. Matro;Brian R. Murphy;Stephen S. Whitehead

  • Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

    Beth D. Kirkpatrick;Anna P. Durbin;Kristen K. Pierce;Marya P. Carmolli

  • Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

    Steevenson Nelson;Christiane A. Jost;Qinq Xu;Jessica Ess

  • Recovery of infectious human parainfluenza virus type 3 from cDNA.

    Anna P. Durbin;Susan L. Hall;Jeffrey W. Siew;Stephen S. Whitehead

  • A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

    Stephen S. Whitehead;Barry Falgout;Kathryn A. Hanley;Joseph E. Blaney

  • A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.

    Kimberly A. Dowd;Christiane A. Jost;Anna P. Durbin;Stephen S. Whitehead

  • A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

    Anna P. Durbin;Beth D. Kirkpatrick;Kristen K. Pierce;Daniel Elwood

  • The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes

    Daniela Weiskopf;Michael A. Angelo;Derek J. Bangs;John Sidney

  • A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development

    Konstantin A. Tsetsarkin;Heather Kenney;Rubing Chen;Guangping Liu

  • Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees.

    Stephen S. Whitehead;Katalin Juhasz;Cai-Yen Firestone;Peter L. Collins

  • Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

    Camilo Ansarah-Sobrinho;Steevenson Nelson;Christiane A. Jost;Stephen S. Whitehead

  • Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

    Joseph E. Blaney;Christopher T. Hanson;Cai-Yen Firestone;Kathryn A. Hanley

  • Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?

    Stephen S. Whitehead

  • Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics

    Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy;Stephen S. Whitehead

Frequent Co-Authors

Anna P. Durbin
Anna P. Durbin Johns Hopkins University
Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
Kathryn A. Hanley
Kathryn A. Hanley New Mexico State University
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Peter L. Collins
Peter L. Collins National Institutes of Health
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Daniela Weiskopf
Daniela Weiskopf La Jolla Institute For Allergy & Immunology
Theodore C. Pierson
Theodore C. Pierson National Institute of Allergy and Infectious Diseases
Cameron P. Simmons
Cameron P. Simmons University College London
Esper G. Kallas
Esper G. Kallas Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can open diverse career pathways. Nursing programs are a strong complement to immunology studies, offering practical skills and patient care experience that are invaluable in clinical and research settings.

If you’re looking to enter the nursing field swiftly, consider programs known for accessibility, such as the easiest accelerated nursing programs. These programs allow students to fast-track their education and begin working sooner.

For those starting their nursing journey, lpn programs with easiest admission requirements can provide a straightforward entry point. Licensed Practical Nurses often work closely with immunologists and medical teams.

Advanced practice roles such as Nurse Practitioners also align well with immunology interests. Programs like nurse practitioner programs with easy admission make this advanced training more accessible.

Specializing in mental health is an option via best online psychiatric mental health nurse practitioner programs, which offer strong clinical placement opportunities and can complement immunological research focused on neuroimmune interactions.

Best Scientists Citing Stephen S. Whitehead

Trending Scientists

Recently Published Articles